Peripheral Artery Disease
353
45
60
192
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
68 trials with published results (19%)
Research Maturity
192 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.1%
18 terminated out of 353 trials
91.4%
+4.8% vs benchmark
10%
34 trials in Phase 3/4
35%
68 of 192 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 192 completed trials
Clinical Trials (353)
Exercise Therapy for PAD Using Mobile Health
Passive Calf Stretching Therapy in Peripheral Artery Disease
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
Community-based Exercise Following Revascularization for PAD
Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions
Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
Improve PAD PERformance With METformin
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
Vascular Regenerative Cell Exhaustion in Adults With Peripheral Artery Disease (PAD-VRCE)
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD
Leg Heat Therapy in Peripheral Artery Disease
Dysvascular Amputation Self-Management of Health
Women's Health Initiative Strong and Healthy Study
Response to Exercise and Nitric Oxide in PAD
Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Home-based Exercise Therapy in Patients With Moderate to Severe Peripheral Artery Disease
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease